
PROPHASE LABS INC by ProPhase Labs fell 99.6% from $1.89 to $0.01, behind the S&P 500's +4.7%. Its worst day was Oct 5 (−29.5%), and its low came Nov 12 at $0.00.
Nov 21, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
PROPHASE LABS INC by ProPhase Labs closed at its highest level of the year, 10.5% above where the year started.
+15.4% · S&P 500 +0.5%
PROPHASE LABS INC by ProPhase Labs shares rose 53.0%, while the S&P 500 rose 0.5%.
Story events cover the past 12 months · Times ET
+53.0%, the year's best day · S&P 500 +0.5%
EPS of $-2.34 was reported on $784,000.00 revenue.
+18.8% · S&P 500 +0.1%
PROPHASE LABS INC by ProPhase Labs shares rose 45.5%, while the S&P 500 fell 1.5%.
+45.5% · S&P 500 −1.5%
EPS of $-0.43 was reported on $478,000.00 revenue.
−13.0% · S&P 500 −0.1%
PROPHASE LABS INC by ProPhase Labs shares rose 42.3%, while the S&P 500 fell 0.0%.
+42.3% · S&P 500 0.0%
EPS of $-0.22 was reported on $1.0M revenue.
−6.8% · S&P 500 −0.8%
PROPHASE LABS INC by ProPhase Labs shares rose 31.7%, while the S&P 500 rose 0.7%.
+31.7% · S&P 500 +0.7%
PROPHASE LABS INC by ProPhase Labs closed at its lowest level of the year, 99.8% below where the year started.
−8.0% · S&P 500 −0.4%
Where it ended: a close of $0.01 on Nov 20, 2026. Up next: Q3 2026 earnings on Dec 4, 2026.
Nothing in the past 12 months.
All PRPH analyst actionsNothing in the past 12 months.
All PRPH dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PRPH and SPY from Benzinga historical bars. Not investment advice.